Mesenchymal stem cell-derived extracellular vesicles enriched with miR-124 exhibit anti-inflammatory effects in collagen-induced arthritis
DOI:
https://doi.org/10.2298/ABS240630030GKeywords:
mesenchymal stem cells, extracellular vesicles, exosome, arthritis, cytokineAbstract
Paper description:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease treated with limited success. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) may help by secreting anti-inflammatory factors.
- We investigated whether human umbilical cord MSC-EVs overexpress miR-124 using lipofectamine 3000 could enhance their therapeutic potential.
- EVs enriched with miR-124 reduced disease severity in a mouse model of arthritis, by modulating inflammatory cytokines.
- MSC-EVs that overexpress specific miRNAs offer a promising cell-free approach for optimizing the treatment of inflammatory joint diseases.
Abstract: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, leading to pain, swelling, stiffness, and joint damage. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) hold significant promise as therapeutic agents owing to their potent paracrine activities. This study investigated the anti-inflammatory effects of human umbilical cord-derived MSC (hUCSC)-EVs overexpressing miR-124 in collagen-induced arthritis (CIA). hUCSCs were transfected with miR-124, and hUCSC-EVs were isolated and characterized. Arthritis was induced in mice by collagen injection, followed by intravenous administration of miR-124 EVs, miR-control, or vehicle. Cytokine levels, including interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, IL-10, and transforming growth factor (TGF)-β, were measured in the joints using real-time PCR by enzyme-linked immunosorbent assay (ELISA). miR-124-hUCSC-EVs showed enrichment of miR-124. In arthritic mice, intravenous treatment with miR-124 EVs significantly reduced the clinical score, increased anti-inflammatory cytokines IL-10 and TGF-β, and lowered inflammatory cytokines IL-6, TNF-α, and IL-1β in the joints. This study shows that miR-124 EVs have anti-inflammatory activity in arthritis by suppressing pro-inflammatory cytokines through miR-124 overexpression. MSC-EVs overexpressed with inflammation-modulating miRNAs offer a promising cell-free approach for treating inflammatory arthritis.
Downloads
References
Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R, Cipriani P. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 2021;20(2):102735. https://doi.org/10.1016/j.autrev.2020.102735
Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62(6):1576-82. https://doi.org/10.1002/art.27425
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338-48. https://doi.org/10.1016/S0140-6736(17)31491-5
Vohra M, Sharma A, Bagga R, Arora SK. Human umbilical cord-derived mesenchymal stem cells induce tissue repair and regeneration in collagen-induced arthritis in rats. J Clin Transl Res. 2020;6(6):203.
Qin L, Liu N, Bao C-l-m, Yang D-z, Ma G-x, Yi W-h, Xiao G-z, Cao H-l. Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin. Acta Pharmacol Sin. 2023;44(2):268-87. https://doi.org/10.1038/s41401-022-00952-0
Azimzadeh M, Mahmoodi M, Kazemi M, Hakemi MG, Jafarinia M, Eslami A, Salehi H, Amirpour N. The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice. Int Immunopharmacol. 2020;87:106808. https://doi.org/10.1016/j.intimp.2020.106808
Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418-37. https://doi.org/10.1111/trf.12421
Skalnikova H, Motlik J, Gadher SJ, Kovarova H. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics. 2011;11(4):691-708. https://doi.org/10.1002/pmic.201000402
Dezfuly AR, Safaee A, Amirpour N, Kazemi M, Ramezani A, Jafarinia M, Dehghani A, Salehi H. Therapeutic effects of human adipose mesenchymal stem cells and their paracrine agents on sodium iodate induced retinal degeneration in rats. Life Sci. 2022;300:120570. https://doi.org/10.1016/j.lfs.2022.120570
Liu H, Li R, Liu T, Yang L, Yin G, Xie Q. Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol. 2020;11:1912. https://doi.org/10.3389/fimmu.2020.01912
Wei W, Huang Y, Li D, Gou H-F, Wang W. Improved therapeutic potential of MSCs by genetic modification. Gene Ther. 2018;25(8):538-47. https://doi.org/10.1038/s41434-018-0041-8
Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3-14. https://doi.org/10.1016/j.addr.2015.05.001
Jafarinia M, Farrokhi MR, Ganjalikhani Hakemi M, Cho WC. The role of miRNAs from mesenchymal stem/stromal cells-derived extracellular vesicles in neurological disorders. Human Cell. 2023;36(1):62-75. https://doi.org/10.1007/s13577-022-00813-2
Renman E, Brink M, Ärlestig L, Rantapää-Dahlqvist S, Lejon K. Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls. Clin Rheumatol. 2021;40:2387-94. https://doi.org/10.1007/s10067-020-05502-9
Sun Y, Li Q, Gui H, Xu D-P, Yang Y-L, Su D-F, Liu X. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res. 2013;23(11):1270-83. https://doi.org/10.1038/cr.2013.116
Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y, Wang K, Wan J. MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PloS One. 2013;8(8):e70300. https://doi.org/10.1371/journal.pone.0070300
Angelopoulou E, Paudel YN, Piperi C. miR-124 and Parkinson’s disease: A biomarker with therapeutic potential. Pharmacol Res. 2019;150:104515. https://doi.org/10.1016/j.phrs.2019.104515
Hassan G, Kasem I, Soukkarieh C, Aljamali M. A simple method to isolate and expand human umbilical cord derived mesenchymal stem cells: using explant method and umbilical cord blood serum. Int J Stem Cells. 2017;10(2):184-92. https://doi.org/10.15283/ijsc17028
Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30(1):3.22. 1-3.. 9. https://doi.org/10.1002/0471143030.cb0322s30
Ahmadvand Koohsari S, Absalan A, Azadi D. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines. Sci Rep. 2021;11(1):11658. https://doi.org/10.1038/s41598-021-91291-3
Withrow J, Murphy C, Liu Y, Hunter M, Fulzele S, Hamrick MW. Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2016;18:1-12. https://doi.org/10.1186/s13075-016-1178-8
Fu H, Hu D, Zhang L, Tang P. Role of extracellular vesicles in rheumatoid arthritis. Mol Immunol. 2018;93:125-32. https://doi.org/10.1016/j.molimm.2017.11.016
Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, Kumagai S. MicroRNA‐124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast‐like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2009;60(5):1294-304. https://doi.org/10.1002/art.24475
Li C, Li X, Zhao B, Wang C. Exosomes derived from miR-544-modified mesenchymal stem cells promote recovery after spinal cord injury. Arch Physiol Biochem. 2020;126(4):369-75. https://doi.org/10.1080/13813455.2019.1691601
Li D, Zhang P, Yao X, Li H, Shen H, Li X, Wu J, Lu X. Exosomes derived from miR-133b-modified mesenchymal stem cells promote recovery after spinal cord injury. Front Neurol. 2018;12:845. https://doi.org/10.3389/fnins.2018.00845
Yang J, Xu C, Wu M, Wu Y, Jia X, Zhou C, Zhang X, Ge S, Li Z, Zhang L. MicroRNA-124 inhibits hepatic stellate cells inflammatory cytokines secretion by targeting IQGAP1 through NF-κB pathway. Int Immunopharmacol. 2021;95:107520. https://doi.org/10.1016/j.intimp.2021.107520
Wang J, Zhang X, Han J, Zhou P, Yu X, Shen Z, Mao R, Lu M, Huang Y, Zhang J. MicroRNA-124 expression in Kupffer cells modulates liver injury by targeting IL-6/STAT3 signaling. Antiviral Res. 2023;211:105510. https://doi.org/10.1016/j.antiviral.2022.105510
Asirvatham AJ, Magner WJ, Tomasi TB. miRNA regulation of cytokine genes. Cytokine. 2009;45(2):58-69. https://doi.org/10.1016/j.cyto.2008.11.010
Papadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I, Fassas A, Anagnostopoulos A, Yannaki E. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Annals Rheum Dis. 2012;71(10):1733-40. https://doi.org/10.1136/annrheumdis-2011-200985
Maumus M, Rozier P, Boulestreau J, Jorgensen C, Noël D. Mesenchymal stem cell-derived extracellular vesicles: opportunities and challenges for clinical translation. Front Bioeng Biotechnol. 2020;8:997. https://doi.org/10.3389/fbioe.2020.00997
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Zhonghua Guo , Mengyuan He, Dongliang Shi , Zhongbo Zhang, Lisha Wang, Bowen Ren, Yunfei Wang , Junjie Wang, Shaoxiang Yang , Hongchao Yu
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.